In addition, our results showed that ESM1 may act as a novel ligand of c-Met and activate the downstream MAPK signaling pathway after binding to c-Met on the surface of endothelial cells to promote the expression of pro-angiogenic molecules, thereby regulating tumor angiogenesis. The gene discussed is MET; the disease is neoplasm.